Gut microbiota-derived metabolites are novel targets for improving insulin resistance

Effects of Hydrogen sulfide on the microbiome: From toxicity to therapy

(2021) Andre G Buret et al.   ANTIOXIDANTS & REDOX SIGNALING

Mechanisms linking gut microbial metabolites to insulin resistance

(2021) Hye Rim Jang et al.   World Journal of Diabetes

Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets

(2020) Hui Wang et al.   Frontiers in Cellular and Infection Microbiology

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

(2020) Sara Vieira-Silva et al.   NATURE

An in vitro evaluation of the effects of different statins on the structure and function of human gut bacterial community

(2020) Changhui Zhao et al.   PLoS One

The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome

(2020) Paulina Markowiak-Kopeć et al.   Nutrients

Sodium glucose co-transporter 2 inhibition reduces succinate levels in diabetic mice

(2020) Lakshini Y Herat et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Gut microbiota in human metabolic health and disease

(2020) Yong Fan et al.   NATURE REVIEWS MICROBIOLOGY

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus

(2020) Qi Zhang et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Metformin and gut microbiota: their interactions and their impact on diabetes

(2019) Natalia G. Vallianou et al.   Hormones-International Journal of Endocrinology and Metabolism

Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia

(2019) Jiyeon Kim et al.   Frontiers in Microbiology

The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity

(2019) Hernández et al.   Nutrients

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice

(2019) Mette Simone Aae Madsen et al.   Scientific Reports

SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice

(2018) Dustin M. Lee et al.   Cardiovascular Diabetology

Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota

(2018) Carolina Serena et al.   ISME Journal

Hydrogen sulfide in physiology and pathogenesis of bacteria and viruses

(2018) Virender Kumar Pal et al.   IUBMB LIFE

A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota

(2018) Li Zhao et al.   Frontiers in Endocrinology

Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome

(2018) Ravinder Nagpal et al.   Scientific Reports

Hydrogen Sulfide and Sulfate Prebiotic Stimulates the Secretion of GLP-1 and Improves Glycemia in Male Mice

(2017) Jennifer Pichette et al.   ENDOCRINOLOGY

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

(2017) Hao Wu et al.   NATURE MEDICINE

The effects of the Lactobacillus casei strain on obesity in children: a pilot study

(2017) S. Nagata et al.   Beneficial Microbes

Microbiota-Produced Succinate Improves Glucose Homeostasis via Intestinal Gluconeogenesis

(2016) Filipe De Vadder et al.   Cell Metabolism

Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases

(2015) Irma Garcia-Martinez et al.   ANTIOXIDANTS & REDOX SIGNALING

Gut metagenome in European women with normal, impaired and diabetic glucose control

(2013) Fredrik H. Karlsson et al.   NATURE

A metagenome-wide association study of gut microbiota in type 2 diabetes

(2012) Junjie Qin et al.   NATURE

Roles of Hydrogen Sulfide in the Pathogenesis of Diabetes Mellitus and Its Complications

(2011) Csaba Szabo   ANTIOXIDANTS & REDOX SIGNALING